I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A Clofazimine-Containing Regimen Confers Improved Treatment..:
Ju Mi Lee
;
Jiyun Park
;
Sangwon Choi
...
https://www.frontiersin.org/articles/10.3389/fmicb.2020.626216/full. , 2021
Link:
https://doi.org/10.3389/fmicb.2020.626216
RT Journal T1 <Title>A Clofazimine-Containing Regimen Confers Improved Treatment Outcomes in Macrophages and in a Murine Model of Chronic Progressive Pulmonary Infection Caused by the Mycobacterium avium Complex</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:544b8bfdc5814164960d64bf4982f711&Exemplar=1&LAN=DE A1 Ju Mi Lee A1 Jiyun Park A1 Sangwon Choi A1 Byung Woo Jhun A1 Su-Young Kim A1 Kyung-Wook Jo A1 Jung Joo Hong A1 Lee-Han Kim A1 Sung Jae Shin PB Frontiers Media S.A. YR 2021 K1 Mycobacterium avium complex-pulmonary disease K1 clofazimine K1 clofazimine-containing regimen K1 standard treatment regimen K1 minimum inhibitory concentrations K1 intracellular drug susceptibility test K1 Microbiology K1 QR1-502 JF https://www.frontiersin.org/articles/10.3389/fmicb.2020.626216/full LK http://dx.doi.org/https://doi.org/10.3389/fmicb.2020.626216 DO https://doi.org/10.3389/fmicb.2020.626216 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
